Weinheim, Germany

Hans-Ulrich Frech

This inventor holds 6 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignee: Gelita Ag. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Ulrich Frech. Retrieved from https://idiyas.com/inventor/hans-ulrich-frech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **The Innovations of Hans-Ulrich Frech: A Pioneer in Collagen Hydrolysate Applications**

Introduction

Hans-Ulrich Frech is a distinguished inventor based in Weinheim, Germany. He is recognized for his contributions to the field of collagen hydrolysate, with a total of five patents under his name. Frech’s innovative work primarily focuses on the therapeutic applications of collagen hydrolysate in treating various health disorders.

Latest Patents

Frech’s recent patents represent significant advancements in the use of collagen hydrolysate. One of his notable inventions involves the use of collagen hydrolysate for addressing inflammatory skin disorders and intestinal conditions. This invention highlights collagen’s potential as an active compound for alleviating symptoms associated with these disorders. Additionally, he has developed a patent aimed at improving endurance performance and stimulating lipid catabolism, particularly by increasing mitochondrial activity. This dual-focus approach also targets weight reduction through enhanced metabolic processes.

Career Highlights

Frech’s career is marked by his association with Gelita AG, where he has furthered research and development in collagen applications. His innovative spirit and dedication have significantly contributed to the understanding and utilization of collagen in both medical and athletic contexts.

Collaborations

Frech collaborates with notable professionals in his field, including Steffen Oesser and Stephan Hausmanns. Working together, they share expertise and insights that fortify their research initiatives and drive innovation within the industry.

Conclusion

Hans-Ulrich Frech stands out as a pioneering figure in the exploration of collagen hydrolysate, with a unique focus on its benefits for skin and intestinal health, as well as athletic performance. His five patents not only showcase his inventive spirit but also the potential for collagen to transform therapeutic practices. As he continues to innovate at Gelita AG, the significance of his work is likely to increase, promising a healthier future for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…